Choksi Laboratories Ltd.

BSE: 526546 SECTOR: Hospital & Healthcare Services  5890   9   0

42.50
-1.35 (-3.08%)
BSE: Today, 03:10 PM

Price Summary

Today's High

₹ 45.75

Today's Low

₹ 42.5

52 Week High

₹ 54

52 Week Low

₹ 0

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

29.6 Cr.

Enterprise Value

63.95 Cr.

No. of Shares

0.7 Cr.

P/E

9.22

P/B

1.4

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  30.31

CASH

0.41 Cr.

DEBT

34.76 Cr.

Promoter Holding

31.48 %

EPS (TTM)

₹  4.61

Sales Growth

16.95%

ROE

1.16 %

ROCE

6.75%

Profit Growth

107.94 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year16.95%
3 Year-3.8%
5 Year0.88%

Profit Growth

1 Year107.94%
3 Year-49.43%
5 Year-25.34%

ROE%

1 Year1.16%
3 Year-10.05%
5 Year-3.41%

ROCE %

1 Year6.75%
3 Year-0.5%
5 Year3.83%

Debt/Equity

1.9416

Price to Cash Flow

3.76

Interest Cover Ratio

1.11358009408269

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 31.48 0
Dec 2022 31.48 0
Sep 2022 31.48 0
Jun 2022 31.48 0
Mar 2022 31.48 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.0854106042135357.
  • The company has an efficient Cash Conversion Cycle of -699.668639601962 days.

 Limitations

  • The company has shown a poor profit growth of -49.425917835109% for the Past 3 years.
  • The company has shown a poor revenue growth of -3.80156473231088% for the Past 3 years.
  • Company has a poor ROE of -10.0474727443373% over the past 3 years.
  • Company has a poor ROCE of -0.501520946825895% over the past 3 years
  • The company is trading at a high PE of 9.22.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
Net Sales 10.16 8.23 8.68 7.84 9.79
Total Expenditure 5.44 5.94 6.35 5.61 6.31
Operating Profit 4.72 2.29 2.33 2.23 3.48
Other Income 0 0.01 0.02 0.1 0
Interest 0.76 0.75 0.87 0.93 0.94
Depreciation 1.35 1.4 1.31 1.37 1.43
Exceptional Items 0 0 0 0 2.26
Profit Before Tax 2.61 0.15 0.16 0.04 3.37
Tax 0.37 -0.15 0.11 0.17 0.39
Profit After Tax 2.24 0.3 0.06 -0.13 2.99
Adjusted EPS (Rs) 3.22 0.43 0.08 -0.19 4.29

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 31.2 33.75 28.16 25.69 30.04
Total Expenditure 24.87 26.48 25.32 21.56 21.14
Operating Profit 6.33 7.26 2.84 4.13 8.91
Other Income 0.36 0.25 0.33 0.49 0.12
Interest 1.59 1.54 1.89 2.82 3.23
Depreciation 3.16 3.68 4.56 4.6 5.43
Exceptional Items 0 0 -2.43 0 0
Profit Before Tax 1.93 2.29 -5.71 -2.81 0.37
Tax 0.59 0.69 -1.83 -0.2 0.16
Net Profit 1.35 1.6 -3.88 -2.61 0.21
Adjusted EPS (Rs.) 1.93 2.3 -5.58 -3.74 0.3

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 6.97 6.97 6.97 6.97 6.97
Total Reserves 15.43 17.04 13.26 10.78 10.94
Borrowings 5.52 14 27.36 28.82 27.54
Other N/C liabilities 1.16 3.86 1.57 2.06 2.06
Current liabilities 15.6 13.48 14.48 16.22 15.57
Total Liabilities 44.68 55.35 63.63 64.85 63.08
Assets
Net Block 25.63 34.81 33.08 50.32 46.56
Capital WIP 0 3.23 13.06 0.5 1.56
Intangible WIP 0 0 0 0 0.11
Investments 2.99 0 0 0 0
Loans & Advances 0.76 0.7 0.57 0.55 0.33
Other N/C Assets 0.28 0.31 0.37 0.44 0.46
Current Assets 15.02 16.3 16.54 13.03 14.06
Total Assets 44.68 55.35 63.63 64.85 63.08
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 1.93 2.29 -5.71 -2.81 0.37
Adjustment 4.29 4.99 7.08 6.93 8.52
Changes in Assets & Liabilities 1.66 2.68 2.57 -1.34 -2.18
Tax Paid -1.64 -3.07 -1.07 3.11 1.17
Operating Cash Flow 6.25 6.91 2.87 5.9 7.88
Investing Cash Flow -4.92 -9.76 -13.76 -7.65 -2.71
Financing Cash Flow -0.94 2.13 11.09 1.63 -5.07
Net Cash Flow 0.39 -0.72 0.2 -0.12 0.1

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 31.48 31.48 31.48 31.48 31.48
sunil choksi 7.51 7.51 7.51 7.51 7.51
vyangesh choksi 6.42 6.42 6.42 6.42 6.42
sunil kumar choksi 5.74 5.74 5.74 5.74 5.74
sunil kumar choksi... - - - - -
khyati choksi 4.33 4.33 4.33 4.33 4.33
choksi holding com... 4.31 4.31 4.31 4.31 4.31
stela choksi 3.16 3.16 3.16 3.16 3.16
himika choksi - - - - -
himika choksi 0.01 0.01 0.01 0.01 0.01
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 68.52 68.52 68.52 68.52 68.52
sachin seth 4.76 4.76 4.76 4.76 4.76
dheeraj kumar lohia 3.30 4.21 4.35 4.35 4.35
pratap singh hardia 1.39 1.39 1.39 1.32 -
gaurav anand 2.87 2.87 2.87 2.87 2.87
shantanu trivedi 2.15 2.15 2.15 2.15 2.15
timsy kapoor 2.15 2.15 2.15 2.15 2.15
quest laboratories... 2.04 2.04 2.04 2.04 2.04
anil kumar sabarwal 1.71 1.45 1.18 - -
raj kumar lohia - 1.63 1.63 1.63 1.05
bobby mathews - - - - 1.44
badrilal bansal - - - - -
mehul suresh parikh - - - 1.21 1.22
sanjay munje 1.19 1.19 1.19 1.19 1.19
alka jain 1.08 1.08 1.08 1.08 1.08

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Choksi Lab Stock Price Analysis and Quick Research Report. Is Choksi Lab an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Choksi Lab and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 7.8774 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Choksi Lab has a Debt to Equity ratio of 1.9416 , which is a weak indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Choksi Lab , the EPS growth was 107.938458250975 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Choksi Lab has OPM of 29.6463962239657 % which is a good sign for profitability.
     
  • ROE: Choksi Lab have a poor ROE of 1.1613294136128 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Choksi Lab

X